Globus Medical, Inc. (GMED) is a Healthcare stock trading at $85.69 (as of 2026-08-20), with a market capitalization of $11.51B and a trailing P/E of 21.5. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal conditions, with offerings that include spine systems (such as fusion and motion preservation products), interventional pain management, and orthopedic trauma and joint products. It also distributes human cell, tissue, and cellular and tissue-based products.
Globus Medical makes and commercializes spine and other musculoskeletal medical devices, including fusion implants, motion preservation technologies, and interventional pain solutions, and it earns money by selling these healthcare products to providers in the United States and internationally.
The company’s profit engine is dominated by its base musculoskeletal device business, because the largest portion of revenue comes from its musculoskeletal solutions and base revenue (with enabling technologies representing a much smaller revenue contribution).
| Base Ex Nevro | $0.7B |
| Nevro | $0.1B |
| Enabling Tech | $0.0B |
Business quality (Solid): High reported margins, with revenue largely coming from the core musculoskeletal device business, but investors should watch how much results depend on specific product platforms and enabling-technology adoption.
Valuation: At 19× earnings, GMED trades 43% below the Medical Equipment average (32×). Note: one-time items can distort reported P/E.
| Price | $85.69 |
| Market Cap | $11.51B |
| P/E Ratio | 21.5 |
| EV / EBITDA | 12.0 |
| Price / Book | 2.41 |
| Price / Sales | 3.66 |
| FCF Yield | 6.6% |
| DCF Value (model) | $51.69 |
| DCF Upside vs Price | -39.7% |
| Revenue (TTM) | $2.94B |
| Net Margin | 18.3% |
| Revenue Growth (YoY) | 5.9% |
| EPS Growth (YoY) | -25.3% |
| FCF Growth (YoY) | 464.1% |
| Altman Z-Score | 11.12 (safe) |
| Stock P/E | 21.5 |
| Sector P/E (Healthcare) | 21.6 |
| Industry P/E (Medical Equipment) | 32.9 |
| vs Sector | -0.5% |
| vs Industry | -34.6% |
| Top Institutional Holder | VANGUARD GROUP INC ($921.07M) |
| Institutional Holders Tracked | 10 |
| Congressional Trades (recent) | 9 |
| Sector | Healthcare |
| Industry | Medical Equipment |
| CEO | Keith W. Pfeil |
| Employees | 5,300 |
| Country | US |
| IPO Date | 2012-08-03 |
Data as of 2026-08-20.
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.